BRISTOL-MYERS SQUIBB COMPANY for BRISTOL-MYERS SQUIBB COMPANY
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R.1492, Ensuring Pathways to Innovation Cures (EPIC) Act Implementation of Inflation Reduction Act of 2022 ORPHAN Cures Act MINI Act H.R.4299, the Protecting Patient Access to Cancer and Complex Therapies Act of 2025
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BRUNET | — |
| MICHAEL CALVO New | U.S. House-Rep. Charles Taylor-LC , LA, SLA 2004 - 2007; Rep. Patrick McHenry-Policy Advisor 2007; Rep. Phil Gingrey SLA, SPA, LD, DepCoS 2007-2015; Rep. Jody Hice, LD 2015 -2016 |
| RODGER CURRIE | — |
| SOFIA FOX | — |
| KIRBY MILLER | — |
| LANE PENRY | — |
Medicare/Medicaid MMM
Issues related to the 340B Drug Pricing Program - regarding all bio-pharmaceutical related provisions H.R.7635, the 340B PATIENTS Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL CALVO | U.S. House-Rep. Charles Taylor-LC , LA, SLA 2004 - 2007; Rep. Patrick McHenry-Policy Advisor 2007; Rep. Phil Gingrey SLA, SPA, LD, DepCoS 2007-2015; Rep. Jody Hice, LD 2015 -2016 |
| RODGER CURRIE | — |
| JOHN DEOUDES | — |
| SOFIA FOX | — |
| KATHRYN NOVARIA | — |
| LANE PENRY | — |
Taxation/Internal Revenue Code TAX
Proposed policies regarding corporate tax reform - regarding all bio-pharmaceutical related provisions Discussions regarding OECD implementation
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL CALVO New | U.S. House-Rep. Charles Taylor-LC , LA, SLA 2004 - 2007; Rep. Patrick McHenry-Policy Advisor 2007; Rep. Phil Gingrey SLA, SPA, LD, DepCoS 2007-2015; Rep. Jody Hice, LD 2015 -2016 |
| RODGER CURRIE | — |
| JOHN DEOUDES | — |
| LANE PENRY | — |
Copyright/Patent/Trademark CPT
Intellectual Property Reform concerning bio-pharmaceutical industry
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BRUNET | — |
| MICHAEL CALVO New | U.S. House-Rep. Charles Taylor-LC , LA, SLA 2004 - 2007; Rep. Patrick McHenry-Policy Advisor 2007; Rep. Phil Gingrey SLA, SPA, LD, DepCoS 2007-2015; Rep. Jody Hice, LD 2015 -2016 |
| RODGER CURRIE | — |
| SOFIA FOX | — |
| KATHRYN NOVARIA | — |
| LANE PENRY | — |
Trade (domestic/foreign) TRD
International Reference Pricing/Most Favored Nation, including all bio-pharmaceutical issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL CALVO New | U.S. House-Rep. Charles Taylor-LC , LA, SLA 2004 - 2007; Rep. Patrick McHenry-Policy Advisor 2007; Rep. Phil Gingrey SLA, SPA, LD, DepCoS 2007-2015; Rep. Jody Hice, LD 2015 -2016 |
| RODGER CURRIE | — |
| JOHN DEOUDES | — |
| SOFIA FOX | — |
| KIRBY MILLER | — |
| KATHRYN NOVARIA | — |
| LANE PENRY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.